Billing and Coding: Therapeutic Apheresis for Familial Hypercholesterolemia
National · Effective Jan 22, 2026
2 active Medicare policies list 36516, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
National · Effective Jan 22, 2026
National · Effective Nov 6, 2025
6 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 36516 |
|---|---|---|
| Alzheimer's Disease: Experimental, Investigational, or Unproven Treatments | Feb 20, 2024 | Covered |
| Extracorporeal Immunoadsorption (Prosorba Column) | Jun 5, 2023 | Covered |
| Policy | Effective | Status of 36516 |
|---|---|---|
| Therapeutic Apheresis | Apr 15, 2026 | Covered |
| Policy | Effective | Status of 36516 |
|---|
| Apheresis | Jan 1, 2026 | Covered |
|---|
| Policy | Effective | Status of 36516 |
|---|---|---|
| Apheresis | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 36516 |
|---|---|---|
| Apheresis | Jan 1, 2026 | Covered |